Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3146 (LINC03146) is a member of the long intergenic non-coding RNA (lincRNA) family, a class of RNAs longer than 200 nucleotides that do not code for proteins and are transcribed from genomic regions lying outside known protein-coding genes[3][7]. LincRNAs can modulate gene expression through diverse mechanisms including chromatin remodeling, transcriptional regulation, and gene architecture organization, often with remarkable tissue specificity. While some lincRNAs have well-established roles in gene regulation and disease, the specific biological function of LINC03146 has not been documented in peer-reviewed literature[3][7]. Research into the function of many lincRNAs, including LINC03146, is ongoing, and they are gaining attention for their roles as gene expression regulators and for their potential involvement in various diseases—even if they are not currently classified as direct therapeutic targets[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3146 (LINC03146).